schizophrenia

Comparing cognitive clusters across first- and multiple-episode of psychosis

Authors: Geneviève Sauvé, Ashok Malla, Ridha Joober, Mathieu B Brodeur, Martin Lepage

Journal: Psychiatry Research

Year Published: 2018

Cognitive impairments in psychotic disorders (PD) present heterogeneously across patients. Between 2 and 5 clusters have been identified in previous studies with first-episode (FEP) and multiple-episodes of psychosis (MEP) patients suggesting different profiles of impairment. Past […]

Similar psychotic and cognitive profile between ketamine dependence with persistent psychosis and schizophrenia

Authors: Wan-Ju Cheng, Chun-Hsin Chen, Chih-Ken Chen, Ming-Chyi Huang, Robert H Pietrzak, John H Krystal, Ke Xu

Journal: Schizophrenia Research

Year Published: 2018

Background: Ketamine has been used to probe the biology of psychosis and cognitive dysfunction in humans. High levels of ketamine abuse are associated with persisting psychosis (KPP) in a minority of users. However, relatively little is […]

Stimulating cognition in schizophrenia: A controlled pilot study of the effects of prefrontal transcranial direct current stimulation upon memory and learning

Authors: Natasza D Orlov, Derek K Tracy, Daniel Joyce, Shinal Patel, Joanna Rodzinka-Pasko, Hayley Dolan, John Hodsoll, Tracy Collier, John Rothwell, Sukhwinder S Shergill

Journal: Brain Stimulation

Year Published: 2017

Background: Schizophrenia is characterized by prominent cognitive deficits, impacting on memory and learning; these are strongly associated with the prefrontal cortex. Objective/Hypothesis: To combine two interventions, transcranial direct current stimulation (tDCS) over the prefrontal cortex and […]

Efficacy and Safety of Lurasidone in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study

Authors: Robert Goldman, Antony Loebel, Josephine Cucchiaro, Ling Deng, Robert L Findling

Journal: Journal of Child and Adolescent Psychopharmacology

Year Published: 2017

Objective: To evaluate the efficacy and safety of lurasidone in acutely symptomatic adolescent patients with schizophrenia. Methods: Patients aged 13-17 years were randomly assigned to 6 weeks of double-blind, fixed-dose lurasidone (40 or 80 mg/day) or […]

Does the Beck Cognitive Insight Scale Predict Response to Cognitive Remediation in Schizophrenia?

Authors: Audrey Benoit, Philippe-Olivier Harvey, Louis Bherer, Martin Lepage

Journal: Schizophrenia Research and Treatment

Year Published: 2016

Cognitive remediation therapy (CRT) has emerged as a viable treatment option for people diagnosed with schizophrenia presenting disabling cognitive deficits. However, it is important to determine which variables can influence response to CRT in order to […]

1 2 3 4 5 7

Back to Publications